Genetic variation in IL28B: impact on drug development for chronic hepatitis C infection.
Journal Article
As more pharmacogenomic insights into diseases and their treatments and toxicities are published each year, the challenge arises to incorporate such insights into clinical practice and drug development. For instance, recent genomic discoveries related to hepatitis C offer a challenge to clinicians, researchers,and health administrators to translate this information into knowledge in order to develop safer and more effective therapeutic strategies for all patients.
Full Text
Duke Authors
Cited Authors
- Clark, PJ; Thompson, AJV; McHutchison, JG
Published Date
- November 2010
Published In
Volume / Issue
- 88 / 5
Start / End Page
- 708 - 711
PubMed ID
- 20881951
Pubmed Central ID
- 20881951
Electronic International Standard Serial Number (EISSN)
- 1532-6535
Digital Object Identifier (DOI)
- 10.1038/clpt.2010.185
Language
- eng
Conference Location
- United States